Journal Browser

Go Edit a Special Issue


Special Issue Title:

Severe Trauma Patients in Critical Care

Deadline for manuscript submissions: 20 September 2021

Print Special Issue Flyer (10)

Special Issue Editor

  • Guest Editor

    Dr. Ignacio Morales-CanéE-MailWebsite

    Intensive Care Unit / General Hospital, Reina Sofía University Hospital, Avenida Menendez Pidal s/n, 1ºB, 14006, Córdoba, Spain

    Interests: Nursing science, Emergency medicine, Emergency medical care, Severe trauma, Critical care

Special Issue Information

The specific characteristics of the severe trauma patient determine its complexity in the approach both in prehospital and hospital settings. There are numerous difficulties that healthcare personnel encounter when approaching this critical patient, influencing the outcome.

At the prehospital level, for example, there is controversy in the administration of fluid therapy and the amount or whether the use of blood products is required. On the other hand, the time-dependent nature of the pathology offers an added difficulty when making decisions and applying the appropriate treatment.

At the hospital level, the main limitation is the definition and classification of the severe trauma patient, with heterogeneity depending on each hospital center or region.

The management of severe trauma patients in intensive care units (ICU) is key to the outcome of these patients. In the ICUs, treatment of the patient with severe trauma is started. Depending on the evolution during the stay in the intensive care unit, the patient may develop sepsis, respiratory distress (as a consequence of a pulmonary contusion) or multi-organ failure that requires greater number of invasive and supportive measures, triggering an increase in ICU length of stay and thus a greater probability of nosocomial infections and sequelae.

Therefore, it is necessary to pay attention to the care required by patients admitted to ICU and, specifically, to severe trauma patients, with the aim of avoiding long length of stays that predispose to infections, sepsis, organ failure and an increase in sequelae or even death.


Critical care, Intensive care units, Severe trauma, Nursing, Length of stay

Manuscript Submission Information

Manuscripts should be submitted online by submit system. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Original articles, case reports or comprehensive reviews are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website. Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Signa Viate is an international peer-reviewed open access journal published by MRE Press. As of January 2021, Signa Vitae will change to a bimonthly journal. Please visit the Instructions for Authors page before submitting a manuscript.The Article Processing Charge (APC) for publication in this open access journal is $1200. We normally offer a discount greater than 30% to all contributors invited by the Editor-in-Chief, Guest Editor (GE) and Editorial board member. Submitted papers should be well formatted and use good English.

Share This Special Issue

Plan Papers (0 papers)

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,200 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Chemical Abstracts Service Source Index The CAS Source Index (CASSI) Search Tool is an online resource that can quickly identify or confirm journal titles and abbreviations for publications indexed by CAS since 1907, including serial and non-serial scientific and technical publications.

IndexCopernicus The Index Copernicus International (ICI) Journals database’s is an international indexation database of scientific journals. It covered international scientific journals which divided into general information, contents of individual issues, detailed bibliography (references) sections for every publication, as well as full texts of publications in the form of attached files (optional). For now, there are more than 58,000 scientific journals registered at ICI.

Geneva Foundation for Medical Education and Research The Geneva Foundation for Medical Education and Research (GFMER) is a non-profit organization established in 2002 and it works in close collaboration with the World Health Organization (WHO). The overall objectives of the Foundation are to promote and develop health education and research programs.

Scopus: CiteScore 0.5(2021) Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.

Embase Embase (often styled EMBASE for Excerpta Medica dataBASE), produced by Elsevier, is a biomedical and pharmacological database of published literature designed to support information managers and pharmacovigilance in complying with the regulatory requirements of a licensed drug.

Submission Turnaround Time